ストックスクリーナーアプリを入手
16.14
0.49%
-0.08
プレマーケット:
16.22
0.08
+0.50%
前日終値:
$16.22
開ける：
$16.22
24時間の取引高:
818.27K
Relative Volume:
0.70
時価総額：
$2.08B
収益：
$298.30M
当期純損益:
$298.21M
株価収益率:
7.4594
EPS:
2.1637
ネットキャッシュフロー:
$166.93M
1週間 パフォーマンス:
+3.07%
1か月 パフォーマンス:
+5.63%
6か月 パフォーマンス:
+2.22%
1年 パフォーマンス:
+104.05%
1日の値動き範囲:
$16.02
$16.48
1週間の範囲:
$15.47
$16.48
52週間の値動き範囲:
$7.285
$16.88
Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile
名前
Aurinia Pharmaceuticals Inc
セクター
電話
250-744-2487
住所
#140, 14315 - 118 AVENUE, EDMONTON, BC
Compare AUPH vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AUPH
Aurinia Pharmaceuticals Inc
|
16.14 | 2.06B | 298.30M | 298.21M | 166.93M | 2.1637 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-03 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-11-07 | アップグレード | Jefferies | Hold → Buy |
| 2025-11-05 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-07-30 | 再開されました | H.C. Wainwright | Buy |
| 2022-11-04 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-05-05 | 再開されました | Cantor Fitzgerald | Overweight |
| 2021-12-10 | アップグレード | Oppenheimer | Perform → Outperform |
| 2021-10-28 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2021-01-25 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-11-03 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-17 | 開始されました | BTIG Research | Buy |
| 2020-05-05 | 開始されました | Cowen | Outperform |
| 2020-01-10 | 開始されました | Jefferies | Buy |
| 2019-12-16 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-03-16 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2018-02-08 | 開始されました | RBC Capital Mkts | Outperform |
| 2017-10-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-05-18 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-04-11 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-03-22 | 繰り返されました | FBR & Co. | Outperform |
| 2016-12-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2016-08-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2016-06-30 | 開始されました | H.C. Wainwright | Buy |
| 2015-05-08 | 開始されました | MLV & Co | Buy |
すべてを表示
Aurinia Pharmaceuticals Inc (AUPH) 最新ニュース
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Screens as Strong Candidate Based on Minervini Trend Template and High Growth Momentum Rating - ChartMill
13D Filings -- Barrons.com - Moomoo
A Fresh Look At Aurinia Pharmaceuticals (AUPH) Valuation After Recent Share Price Consolidation - Yahoo Finance
Aurinia (NASDAQ: AUPH) director receives grant of 23,931 stock options - Stock Titan
Aurinia (NASDAQ: AUPH) director awarded 23,931 stock options expiring 2036 - Stock Titan
Aurinia Pharmaceuticals (AUPH) director receives 23,931 share option grant - Stock Titan
Aurinia (AUPH) director Jeffrey Bailey granted 23,931 stock options at $15.67 - Stock Titan
Avoiding Lag: Real-Time Signals in (AUPH) Movement - Stock Traders Daily
Aurinia Pharmaceuticals' (AUPH) CEO Bought 815,000 Shares for $12.5 Million - The Motley Fool
AUPH Stock Sees Biggest Single-Day Drop In More Than 9 Months Despite Q1 Earnings Beat – Here’s What’s Spooking Investors - Stocktwits
TANG KEVIN C's Strategic Acquisition in Aurinia Pharmaceuticals Inc - GuruFocus
Insider sales, option exercise at AUPH (NASDAQ: AUPH) reported - Stock Titan
10 Health Care Stocks Whale Activity In Today's Session - Benzinga
Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Tang group discloses 10% Aurinia (AUPH) stake plus $15 put options - Stock Titan
Strong shareholder support for Aurinia (NASDAQ: AUPH) board, auditor and say-on-pay - Stock Titan
AUPH: 25,000-share option exercise filed; Keenan sold 25,000 on 06/02/2026 - Stock Titan
Aurinia: Cash-Generating Today, Pipeline-Driven Tomorrow (NASDAQ:AUPH) - Seeking Alpha
LUPKYNIS Associated with a Statistically Significant 53% Reduction in Risk of Renal-Related Event or Death - Business Wire
AUPH stock rallies after CEO shake-up: Retail bulls bet on turnaround - MSN
Aurinia Pharmaceuticals Insider Bought Shares Worth $12,455,227, According to a Recent SEC Filing - Moomoo
Insider Stock Purchases: June 03, 2026 - Quiver Quantitative
Chief Executive Officer Of Aurinia Pharmaceuticals Makes $12.46M Buy - Benzinga
TANG CAPITAL MANAGEMENT, LLC FILES EARLY WARNING REPORT RESPECTING AURINIA PHARMACEUTICALS INC. - Quantisnow
Funds tied to Aurinia Pharmaceuticals (AUPH) add shares, sell put options - Stock Titan
Aurinia Pharmaceuticals(AUPH.US) 10% Shareholder Buys US$12.46 Million in Common Stock - Moomoo
25,000-Share Sale Notice for AUPH (NASDAQ: AUPH) - Stock Titan
AUPH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Aurinia Stock Dips as Traders Eye Lupkynis Data - Bez Kabli
AUPH Stock Price, Quote & Chart | AURINIA PHARMACEUTICALS INC (NASDAQ:AUPH) - ChartMill
Discipline and Rules-Based Execution in AUPH Response - Stock Traders Daily
AUPH News | AURINIA PHARMACEUTICALS INC (NASDAQ:AUPH) - ChartMill
Aurinia (AUPH) Chief Legal Officer granted 115,541 performance stock units - Stock Titan
Aurinia Pharmaceuticals (AUPH) grants PSUs and stock options to CFO - Stock Titan
Aurinia (AUPH) COO receives 116,144 PSUs and 70,230 stock options - Stock Titan
Aurinia Pharmaceuticals Completes Successful Tender Offer for Kezar Life Sciences - citybiz
Tranche Update on Aurinia Pharmaceuticals Inc.'s Equity Buyback Plan announced on February 15, 2024. - marketscreener.com
Why Aurinia Pharmaceuticals stock is surging Monday morning - MSN
Tangible book value per share of Aurinia Pharmaceuticals Inc. – FWB:IKAP - TradingView
Aurinia Pharmaceuticals stock (CA05156H1070): Q1 revenue beat and July earnings date in focus - AD HOC NEWS
Jefferies Upgrades Aurinia Pharmaceuticals (AUPH) - MSN
Behavioral Patterns of AUPH and Institutional Flows - Stock Traders Daily
Aurinia Pharmaceuticals (AUPH) Price Target Increased by 34.15% to 16.03 - MSN
Aurinia Pharmaceuticals' (NASDAQ:AUPH) Performance Raises Some Questions - simplywall.st
We Believe Aurinia Pharmaceuticals' (NASDAQ:AUPH) Earnings Are A Poor Guide For Its Profitability - Yahoo Finance
Kezar Life Sciences stock (US49374L1008): Merger with Aurinia completes, shares cancelled - AD HOC NEWS
Aurinia Pharmaceuticals IncCommon Shares (NQ: AUPH - FinancialContent
Aurinia deal leaves Kezar (KZR) wholly owned as Tang Capital exits - Stock Titan
Aurinia Pharmaceuticals stock (CA05156H1070): Announces $6.955 Cash Acquisition of Kezar Life Scienc - AD HOC NEWS
Aurinia Pharmaceuticals Inc (AUPH) 財務データ
収益
当期純利益
現金流量
EPS
2.60%
0.94%
大文字化:
|
ボリューム (24 時間):